|
Volumn 8, Issue 3, 2001, Pages 289-299
|
A small molecule designed to bind to the adenine nucleotide pocket of Hsp90 causes Her2 degradation and the growth arrest and differentiation of breast cancer cells
|
Author keywords
Geldanamycin; Her2; Hsp90 inhibitor; Novel anti tumor agent
|
Indexed keywords
ADENINE NUCLEOTIDE;
BENZOQUINONE DERIVATIVE;
EPIDERMAL GROWTH FACTOR RECEPTOR 2;
GELDANAMYCIN;
HEAT SHOCK PROTEIN 90;
MACROCYCLIC LACTAM;
QUINONE DERIVATIVE;
ARTICLE;
BINDING COMPETITION;
BREAST TUMOR;
CELL CULTURE;
CELL CYCLE;
CELL DIFFERENTIATION;
DRUG DESIGN;
DRUG EFFECT;
FEMALE;
HUMAN;
METABOLISM;
PATHOLOGY;
PROTEIN BINDING;
ADENINE NUCLEOTIDES;
BENZOQUINONES;
BINDING, COMPETITIVE;
BREAST NEOPLASMS;
CELL CYCLE;
CELL DIFFERENTIATION;
DRUG DESIGN;
FEMALE;
HSP90 HEAT-SHOCK PROTEINS;
HUMANS;
LACTAMS, MACROCYCLIC;
PROTEIN BINDING;
QUINONES;
RECEPTOR, ERBB-2;
TUMOR CELLS, CULTURED;
|
EID: 0035071607
PISSN: 10745521
EISSN: None
Source Type: Journal
DOI: 10.1016/S1074-5521(01)00015-1 Document Type: Article |
Times cited : (279)
|
References (25)
|